Please assess the completion status of the following clinical trial:

Trial Title: Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient greater than or equal to 18 years of age,~* non-smokers,~* diagnosed with asthma, with an FEV1 less than or equal to 70 percent of predicted normal,~* stable use of Beta agonist~* daily use of inhaled steroids for one year~Exclusion Criteria:~* Patients with other significant diseases other than asthma, requiring oxygen,~* intubated within 5 years,~* asthma exacerbation within 6 weeks of trial,~* use of unstable doses (greater than 10 mg/day of prednisone or equivalent) of steroids,~* participating in another interventional trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).